Brenzavvy® (bexagliflozin) is a prescription medication used to help manage blood sugar levels in adults with type 2 diabetes. It belongs to a class of drugs called sodium-glucose co-transporter 2 (SGLT2) inhibitors, which work by preventing the kidneys from reabsorbing glucose back into the bloodstream, allowing excess sugar to be excreted through urine. Brenzavvy® is typically used in combination with diet and exercise to improve glycemic control and may also offer benefits such as modest weight loss and blood pressure reduction. It is not indicated for type 1 diabetes or diabetic ketoacidosis.